25 Jun 2020
Target all comers 3-year results - Evaluation of Cobalt Chrome Rapamycin Drug Eluting Stent
This Hot Line was presented at PCR e-Course 2020
Summary
Watch this session if you want to review the Firehawk family TES technology and early clinical outcomes in the treatment of atherosclerotic lesions, to gain the first sight of the 3-year results of the TARGET AC trial and to look into the Future Directions of Target series clinical trials.
Videos included on this page: the Hot Line presentation and a Wrap Up discussion.
